
Company valuation, historical trends, and peer comparisons.
According to Cue Biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 138.85M. This represents a change of 92.34% compared to the average of 72.19M of the last 4 quarters.
The mean historical Enterprise Value of Cue Biopharma, Inc. over the last ten years is 159.21M. The current 138.85M Enterprise Value has changed -12.79% with respect to the historical average. Over the past ten years (40 quarters), CUE's Enterprise Value was at its highest in in the June 2020 quarter at 640.39M. The Enterprise Value was at its lowest in in the September 2016 quarter at 0.
Average
159.21M
Median
133.00M
Minimum
5.99M
Maximum
311.42M
Discovering the peaks and valleys of Cue Biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 321.81%
Maximum Annual Enterprise Value = 311.42M
Minimum Annual Increase = -87.48%
Minimum Annual Enterprise Value = 5.99M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 5.99M | -87.48% |
| 2024 | 47.81M | -45.02% |
| 2023 | 86.97M | 25.50% |
| 2022 | 69.30M | -77.01% |
| 2021 | 301.49M | 3.54% |
| 2020 | 291.17M | -6.50% |
| 2019 | 311.42M | 321.81% |
| 2018 | 73.83M | -58.76% |
| 2017 | 179.02M | -20.48% |
| 2016 | 225.12M | 184.58% |
The current Enterprise Value of Cue Biopharma, Inc. (CUE) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
46.92M
5-year avg
102.31M
10-year avg
159.21M
Cue Biopharma, Inc.’s Enterprise Value is greater than NRx Pharmaceuticals, Inc. (70.89M), greater than Outlook Therapeutics, Inc. (123.00M), greater than Equillium, Inc. (30.29M), less than Coeptis Therapeutics Holdings, Inc. (180.08M), greater than Spruce Biosciences, Inc. (43.73M), greater than IO Biotech, Inc. (-28323310.00), less than Century Therapeutics, Inc. (251.16M), greater than Medicus Pharma Ltd. Common Stock (7.27M), greater than Senti Biosciences, Inc. (19.73M), greater than Barinthus Biotherapeutics plc (-18767734.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 70.89M | $96.33M | |
| 123.00M | $115.81M | |
| 30.29M | $86.87M | |
| 180.08M | $38.62M | |
| 43.73M | $132.35M | |
| -28323310.00 | $885.69K | |
| 251.16M | $266.18M | |
| 7.27M | $2.71M | |
| 19.73M | $5.97M | |
| -18767734.00 | $30.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cue Biopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cue Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cue Biopharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Cue Biopharma, Inc. (CUE)?
What is the 3-year average Enterprise Value for Cue Biopharma, Inc. (CUE)?
What is the 5-year average Enterprise Value for Cue Biopharma, Inc. (CUE)?
How does the current Enterprise Value for Cue Biopharma, Inc. (CUE) compare to its historical average?